GL
Gila Lustig

Publications (14)

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation
Article scientifique · 2024
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Article scientifique · 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Article scientifique · 2023
Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa
Article scientifique · 2023
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Erratum · 2022
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Article scientifique · 2022
Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity
Article scientifique · 2022
Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against Omicron
Article scientifique · 2022
T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
Article scientifique · 2021
HIV cell-to-cell spread slows evolution of drug resistance
Article scientifique · 2020
Interference with HIV infection of the first cell is essential for viral clearance at sub-optimal levels of drug inhibition
Article scientifique · 2020
Interference with HIV infection of the first cell is essential for viral clearance in a pre-exposure prophylaxis model
Article scientifique · 2018
Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death
Article scientifique · 2017
HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell
Article scientifique · 2016

Domaines principaux

Sciences de la santé14

Statistiques

Consultations43
Téléchargements0